Name | Type | Posted | Actions |
|---|---|---|---|
Sol_75N94024R00003_Amd_0002.pdf | Aug 30, 2024 | ||
SBCX_Industry_Subcontracting_Guide_0002.pdf | Aug 30, 2024 | ||
Sol_75N94024R00003_Amd_0001.pdf | Aug 23, 2024 | ||
Amend_01_Att_01_02_03_RFP_75N94024R00003_8_23_24_0001.pdf | Aug 23, 2024 | ||
Sol_75N94024R00003.pdf | Aug 19, 2024 | ||
att_24_links.pdf | Aug 19, 2024 |
A--PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE MO
A--PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE MO
The National Institutes of Health and the National Institute of Child Health and Human Development have issued solicitation 75N94024R00003 to secure preclinical medications screening services using dependence models of alcohol use disorder. This research initiative involves evaluating potential therapeutic compounds to determine their effectiveness in addressing physiological and behavioral aspects of alcohol dependence. The requirement is classified under NAICS code 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC code AJ11 for GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH.
Responses to this solicitation are due by September 18, 2024. The procurement includes six total attachments, comprising the original solicitation, two amendments, and industry subcontracting guides. Lisa L. Schaupp serves as the point of contact for this requirement, which was originally published on August 19, 2024, and updated through August 30, 2024. All work performed under this solicitation supports the basic research objectives of the agency regarding substance use disorders.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
SCHAUPP, LISA L
Not specified
PRECLINICAL MEDICATIONS SCREENING IN DEPENDENCE MODELS OF ALCOHOL USE DISORDER